Director, National Affairs
Michael Collins is director at the Drug Policy Alliance's Office of National Affairs, in Washington, D.C., where he works with Congress on a wide variety of drug policy issues including marijuana reform, criminal justice reform, overdose issues, and more. He is originally from Scotland, and lived in France, Spain and Mexico, before moving to the U.S.
Before joining DPA, Michael worked at the Information Technology Industry Council, interned in the U.S. House of Representatives, and worked on drug war issues in Mexico for the CIP Americas Program. He holds a Master’s degree from Georgetown University’s School of Foreign Service, where he studied international relations. He also has an undergraduate degree from Strathclyde University in his hometown of Glasgow. He speaks French, Spanish and Catalan.
Michael has been involved in several drug policy victories, such as the passage of the Rohrabacher-Farr amendment, funding for diversion programs, legalizing marijuana in Washington, D.C., and the First Step Act. He has also helped defeat proposals to increase penalties for fentanyl, such as SITSA, and the Ayotte amendment. He has also been involved in the development of groundbreaking legislation such as the Marijuana Justice Act and Bernie Sanders’ marijuana reform bill.
Michael has discussed drug policy issues on CNN, CBS, the BBC, and Democracy Now. He has also appeared in the New York Times, Washington Post, and Wall Street Journal. Michael has written several op-eds on drug policy, including one in early 2018, published by CNN, warning against increasing penalties for fentanyl. He is the co-author of a 2018 report on drug policy in Spain: “Better to Ask Forgiveness than Permission.”
In his free time, he enjoys watching football (soccer), especially his beloved Glasgow Celtic and FC Barcelona, reading books, watching films, and occasionally dj’ing – on special request.